|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SNX12-MMP2 (FusionGDB2 ID:84300) |
Fusion Gene Summary for SNX12-MMP2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SNX12-MMP2 | Fusion gene ID: 84300 | Hgene | Tgene | Gene symbol | SNX12 | MMP2 | Gene ID | 29934 | 4313 |
Gene name | sorting nexin 12 | matrix metallopeptidase 2 | |
Synonyms | - | CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1 | |
Cytomap | Xq13.1 | 16q12.2 | |
Type of gene | protein-coding | protein-coding | |
Description | sorting nexin-12 | 72 kDa type IV collagenasecollagenase type IV-Amatrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)matrix metalloproteinase-2matrix metalloproteinase-IIneutrophil gelatinase | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | Q9H239 | |
Ensembl transtripts involved in fusion gene | ENST00000374274, ENST00000465030, ENST00000276105, | ENST00000570308, ENST00000219070, ENST00000543485, ENST00000437642, | |
Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 7 X 7 X 4=196 |
# samples | 4 | 7 | |
** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SNX12 [Title/Abstract] AND MMP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SNX12(70279597)-MMP2(55525772), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SNX12 | GO:0010955 | negative regulation of protein processing | 22709416 |
Hgene | SNX12 | GO:0042177 | negative regulation of protein catabolic process | 22719997 |
Hgene | SNX12 | GO:0051224 | negative regulation of protein transport | 22719997 |
Hgene | SNX12 | GO:2000642 | negative regulation of early endosome to late endosome transport | 22719997 |
Tgene | MMP2 | GO:0006508 | proteolysis | 15863497 |
Fusion gene breakpoints across SNX12 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MMP2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | DA812017 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
Top |
Fusion Gene ORF analysis for SNX12-MMP2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000374274 | ENST00000570308 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000374274 | ENST00000219070 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000374274 | ENST00000543485 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000374274 | ENST00000437642 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000465030 | ENST00000570308 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000465030 | ENST00000219070 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000465030 | ENST00000543485 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000465030 | ENST00000437642 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000276105 | ENST00000570308 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000276105 | ENST00000219070 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000276105 | ENST00000543485 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
intron-3CDS | ENST00000276105 | ENST00000437642 | SNX12 | chrX | 70279597 | - | MMP2 | chr16 | 55525772 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for SNX12-MMP2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SNX12-MMP2 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | MMP2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Can degrade casein. Could play a role in tissues homeostasis and repair. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for SNX12-MMP2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for SNX12-MMP2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SNX12-MMP2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SNX12-MMP2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | MMP2 | C0027627 | Neoplasm Metastasis | 6 | CTD_human |
Tgene | MMP2 | C0027626 | Neoplasm Invasiveness | 4 | CTD_human |
Tgene | MMP2 | C1850155 | TORG-WINCHESTER SYNDROME | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | MMP2 | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
Tgene | MMP2 | C0006663 | Calcinosis | 2 | CTD_human |
Tgene | MMP2 | C0009402 | Colorectal Carcinoma | 2 | CTD_human;UNIPROT |
Tgene | MMP2 | C0009404 | Colorectal Neoplasms | 2 | CTD_human |
Tgene | MMP2 | C0023890 | Liver Cirrhosis | 2 | CTD_human |
Tgene | MMP2 | C0023893 | Liver Cirrhosis, Experimental | 2 | CTD_human |
Tgene | MMP2 | C0027051 | Myocardial Infarction | 2 | CTD_human |
Tgene | MMP2 | C0239946 | Fibrosis, Liver | 2 | CTD_human |
Tgene | MMP2 | C0263628 | Tumoral calcinosis | 2 | CTD_human |
Tgene | MMP2 | C0376634 | Craniofacial Abnormalities | 2 | CTD_human |
Tgene | MMP2 | C0521174 | Microcalcification | 2 | CTD_human |
Tgene | MMP2 | C0678222 | Breast Carcinoma | 2 | CTD_human |
Tgene | MMP2 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Tgene | MMP2 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Tgene | MMP2 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Tgene | MMP2 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | MMP2 | C0002152 | Alloxan Diabetes | 1 | CTD_human |
Tgene | MMP2 | C0003493 | Aortic Diseases | 1 | CTD_human |
Tgene | MMP2 | C0003496 | Aortic Rupture | 1 | CTD_human |
Tgene | MMP2 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | MMP2 | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human |
Tgene | MMP2 | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Tgene | MMP2 | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Tgene | MMP2 | C0005940 | Bone Diseases | 1 | CTD_human |
Tgene | MMP2 | C0005944 | Metabolic Bone Disorder | 1 | CTD_human |
Tgene | MMP2 | C0005967 | Bone neoplasms | 1 | CTD_human |
Tgene | MMP2 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | MMP2 | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Tgene | MMP2 | C0015934 | Fetal Growth Retardation | 1 | CTD_human |
Tgene | MMP2 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | MMP2 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | MMP2 | C0019207 | Hepatoma, Morris | 1 | CTD_human |
Tgene | MMP2 | C0019208 | Hepatoma, Novikoff | 1 | CTD_human |
Tgene | MMP2 | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | MMP2 | C0021368 | Inflammation | 1 | CTD_human |
Tgene | MMP2 | C0022682 | Kienbock Disease | 1 | CTD_human |
Tgene | MMP2 | C0023283 | Leishmaniasis, Cutaneous | 1 | CTD_human |
Tgene | MMP2 | C0023891 | Liver Cirrhosis, Alcoholic | 1 | CTD_human |
Tgene | MMP2 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Tgene | MMP2 | C0024143 | Lupus Nephritis | 1 | CTD_human |
Tgene | MMP2 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | MMP2 | C0024689 | Mandibular Diseases | 1 | CTD_human |
Tgene | MMP2 | C0024796 | Marfan Syndrome | 1 | CTD_human |
Tgene | MMP2 | C0024950 | Maxillary Diseases | 1 | CTD_human |
Tgene | MMP2 | C0027439 | Nasopharyngeal Neoplasms | 1 | CTD_human |
Tgene | MMP2 | C0027543 | Avascular necrosis of bone | 1 | CTD_human |
Tgene | MMP2 | C0028433 | Nose Neoplasms | 1 | CTD_human |
Tgene | MMP2 | C0029172 | Oral Submucous Fibrosis | 1 | CTD_human |
Tgene | MMP2 | C0029445 | Bone necrosis | 1 | CTD_human |
Tgene | MMP2 | C0029453 | Osteopenia | 1 | CTD_human |
Tgene | MMP2 | C0029463 | Osteosarcoma | 1 | CTD_human |
Tgene | MMP2 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Tgene | MMP2 | C0034067 | Pulmonary Emphysema | 1 | CTD_human |
Tgene | MMP2 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Tgene | MMP2 | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
Tgene | MMP2 | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | MMP2 | C0085762 | Alcohol abuse | 1 | PSYGENET |
Tgene | MMP2 | C0086404 | Experimental Hepatoma | 1 | CTD_human |
Tgene | MMP2 | C0086540 | Leishmaniasis, New World | 1 | CTD_human |
Tgene | MMP2 | C0086541 | Urban cutaneous leishmaniasis | 1 | CTD_human |
Tgene | MMP2 | C0162872 | Aortic Aneurysm, Thoracic | 1 | CTD_human |
Tgene | MMP2 | C0221227 | Centriacinar Emphysema | 1 | CTD_human |
Tgene | MMP2 | C0235874 | Disease Exacerbation | 1 | CTD_human |
Tgene | MMP2 | C0238301 | Cancer of Nasopharynx | 1 | CTD_human |
Tgene | MMP2 | C0264393 | Panacinar Emphysema | 1 | CTD_human |
Tgene | MMP2 | C0271673 | Symmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | MMP2 | C0271674 | Asymmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | MMP2 | C0271678 | Diabetic Mononeuropathy | 1 | CTD_human |
Tgene | MMP2 | C0271680 | Diabetic Polyneuropathies | 1 | CTD_human |
Tgene | MMP2 | C0271685 | Diabetic Amyotrophy | 1 | CTD_human |
Tgene | MMP2 | C0271686 | Diabetic Autonomic Neuropathy | 1 | CTD_human |
Tgene | MMP2 | C0279530 | Malignant Bone Neoplasm | 1 | CTD_human |
Tgene | MMP2 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Tgene | MMP2 | C0340630 | Aortic Aneurysm, Thoracoabdominal | 1 | CTD_human |
Tgene | MMP2 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Tgene | MMP2 | C0393835 | Diabetic Asymmetric Polyneuropathy | 1 | CTD_human |
Tgene | MMP2 | C0520474 | Aseptic Necrosis of Bone | 1 | CTD_human |
Tgene | MMP2 | C0741160 | Aortic Aneurysm, Ruptured | 1 | CTD_human |
Tgene | MMP2 | C0751074 | Diabetic Neuralgia | 1 | CTD_human |
Tgene | MMP2 | C0751394 | Cancer of Nose | 1 | CTD_human |
Tgene | MMP2 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | MMP2 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | MMP2 | C1336708 | Testicular Germ Cell Tumor | 1 | CTD_human |
Tgene | MMP2 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Tgene | MMP2 | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | MMP2 | C2350878 | Focal Emphysema | 1 | CTD_human |
Tgene | MMP2 | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
Tgene | MMP2 | C2936380 | Neointima | 1 | CTD_human |
Tgene | MMP2 | C2936381 | Neointima Formation | 1 | CTD_human |
Tgene | MMP2 | C2937358 | Cerebral Hemorrhage | 1 | CTD_human |
Tgene | MMP2 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | MMP2 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | MMP2 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Tgene | MMP2 | C4721507 | Alveolitis, Fibrosing | 1 | CTD_human |
Tgene | MMP2 | C4721845 | Marfan Syndrome, Type I | 1 | CTD_human |